In this deep-dive episode, we unpack DEA Telehealth Prescribing Rules for 2026: What PMHNPs Running a Practice Need to Know. The DEA extended telehealth prescribing flexibilities for controlled substances through December 31, 2026 . PMHNPs can continue prescribing Schedule II-V meds via video without a prior in-person visit — but permanent rules are coming, and they’ll likely tighten requirements. If you’re building or running a telehealth practice, now is the time to audit your documentation, build hybrid workflows, and prepare for a Special Registration for Telemedicine that may become mandatory. The window to build your practice on the current rules is closing. Read the full post: https://psychnpfellowship.com/dea-telehealth-prescribing-rules-2026-pmhnp/